ENSC

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company developing safer prescription drugs using its proprietary technology platforms. The company's Trypsin-Activated Abuse Protection (TAAP) platform is designed to prevent opioid abuse while maintaining pain relief efficacy. Ensysce is also developing overdose protection technology (MPAR) that can slow or stop drug release in overdose situations. The company's pipeline focuses on addressing the opioid crisis through abuse-deterrent and overdose-resistant formulations.